# Neumora Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/neumora-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:16.622146+00:00 | | Last reviewed | 2026-10-16T13:53:16.622146+00:00 | ## Identity - Legal name: Neumora Therapeutics, Inc. - Display name: Neumora Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T13:53:16.622146+00:00 | | Completeness | 0.364 | | Record Quality | 0.821 | | Directors | 6 | | Committees | 7 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alaa Halawa: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7 - David Piacquad: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8 - Kristina Burow: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9 - Matthew Fust: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10 - Maykin Ho: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11 - Paul L. Berns: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12 ## Committees - Audit (audit). Chair: Matthew Fust. Members: Matthew Fust (chair, current); David Piacquad (member, current); Maykin Ho (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Matthew Fust (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:audit-chair-compensation - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Maykin Ho (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:audit-nominating-and-governance - Compensation (compensation). Chair: Kristina Burow. Members: Kristina Burow (chair, current); Alaa Halawa (member, current); Matthew Fust (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Kristina Burow (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:compensation-chair-nominating-and-governance - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Alaa Halawa (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Alaa Halawa. Members: Alaa Halawa (chair, current); Kristina Burow (member, current); Maykin Ho (member, current). committee_id=alpha:committee:neumora-therapeutics-inc:nominating-and-governance ## Governance events - DIRECTOR_APPOINTED: David Piacquad seat on Neumora Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:14dwtl3k1zwcb - COMMITTEE_MEMBER_ADDED: David Piacquad member of Audit, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:lr2mfyfasqt6 - DIRECTOR_APPOINTED: Alaa Halawa seat on Neumora Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:pn9tv3ksuq2h - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Neumora Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:qaz7uhea0a5x - COMMITTEE_MEMBER_ADDED: Alaa Halawa member of Compensation; Nominating and Governance · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1yak1jn1ot30fh - DIRECTOR_APPOINTED: Maykin Ho seat on Neumora Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1uibwmn6l1f65 - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Neumora Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1rvv3tll4wroh - COMMITTEE_MEMBER_ADDED: Maykin Ho member of Audit; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:a59djw1hfcp94 - DIRECTOR_APPOINTED: Kristina Burow seat on Neumora Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:10bfobfappumd - DIRECTOR_APPOINTED: Matthew Fust seat on Neumora Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:xwy7wh1wiv4pt - DIRECTOR_APPOINTED: Paul L. Berns seat on Neumora Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:1ozbe6bbbpdxf - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Neumora Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:encyib1xkb0f1 - COMMITTEE_MEMBER_ADDED: Matthew Fust member of Audit · Chair; Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:19weg1hlsojvb - COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of Neumora Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:186z68dyireo9 - COMMITTEE_MEMBER_ADDED: Kristina Burow member of Compensation · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:16.622146+00:00. event_id=alpha:event:transition:ptwrnp1ii6pyd ## Scoped resources - `alpha://company/neumora-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record - `alpha://company/neumora-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=identity - `alpha://company/neumora-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/neumora-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=board - `alpha://company/neumora-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=committees - `alpha://company/neumora-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=leadership - `alpha://company/neumora-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=ownership - `alpha://company/neumora-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=financials - `alpha://company/neumora-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/neumora-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=compensation - `alpha://company/neumora-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=governance - `alpha://company/neumora-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/neumora-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=audit - `alpha://company/neumora-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=legal - `alpha://company/neumora-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=risk - `alpha://company/neumora-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=cyber - `alpha://company/neumora-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/neumora-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=agents - `alpha://company/neumora-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/neumora-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=events - `alpha://company/neumora-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=relationships - `alpha://company/neumora-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=assessments - `alpha://company/neumora-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:david-piacquad","name":"David Piacquad"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:matthew-fust","name":"Matthew Fust"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:alaa-halawa","name":"Alaa Halawa"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:kristina-burow","name":"Kristina Burow"},"source_id":"board_seats"}` - Claim alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"source_id":"board_seats"}` ## Leadership - Alaa Halawa: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. - David Piacquad: Director, Audit. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. - Kristina Burow: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. - Matthew Fust: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. - Maykin Ho: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. - Paul L. Berns: Director. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Matthew Fust; Members Matthew Fust (Chair); David Piacquad; Maykin Ho. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Compensation: Chair Kristina Burow; Members Kristina Burow (Chair); Alaa Halawa; Matthew Fust. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Nominating and Governance: Chair Alaa Halawa; Members Alaa Halawa (Chair); Kristina Burow; Maykin Ho. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Neumora Therapeutics, Inc.. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. ## Entity Status - Public listing published. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. ## Published Fact - US. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. - Healthcare. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. - Biotechnology. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. ## Committee Appointment - Matthew Fust: chair, Audit. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - David Piacquad: member, Audit. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Maykin Ho: member, Audit. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Kristina Burow: chair, Compensation. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Alaa Halawa: member, Compensation. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Matthew Fust: member, Compensation. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Alaa Halawa: chair, Nominating and Governance. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Kristina Burow: member, Nominating and Governance. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. - Maykin Ho: member, Nominating and Governance. Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988. ## Security Listing - NMRA (NASDAQ). Claim: alpha:claim:company:948332ba-94ed-4db5-986f-ee8b8b7d7d80:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:b2ec121b5b22c10c4aee40929b053d6b41e4f4d3158d6b6e1667ef1cbeaf495a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/neumora-therapeutics-inc). - alpha:projection-evidence:document:59cd978c77a6c3218112b9f745218b0615722da1e066353013a62e51ae648c9a: [Neumora Therapeutics, Inc. DEF 14A 2026-04-17](https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm). - alpha:projection-evidence:8c97057b4c539825c8f47b221fe418e656fdf343e4f1433284f8b6d89d57a988: [Audit](https://www.sec.gov/Archives/edgar/data/1885522/000119312526161489/nmra-20260417.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/neumora-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/neumora-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/neumora-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/neumora-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-16T16:49:55.708558+00:00; recorded 2026-10-16T16:49:55.708558+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.